News for Yield10 Bioscience, Inc. (YTEN)

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets GlobeNewswire July 17, 2024 WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience...

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On June 12, 2024, Yield10 Bioscience, Inc. filed a Certificate of Amendment to its Amended...

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for...

Loading... Loading... Shares of Bolt Biotherapeutics, Inc. BOLT fell sharply during Wednesday's session after the company reported first-quarter financial resu...

Loading... Loading... U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Wednesday. Following the market opening...

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (

Yield10 Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.11. Yield10 Bioscience, Inc.

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Apr 01, 2024 / 08:30PM GMTOperator Welcome to the Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

Discover the success and failures of 189 investment tickers through insightful analysis from 2020-2023, offering key takeaways for financial growth.

2023 was an amazing year for stock pickers, with an impressive 98.4% return on two portfolios. Click here to find out what did and didn't work in 2023.

Despite the high level of difficulty, the small-cap value universe can offer some of the best ways to generate alpha. Explore more details here.

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading

/PRNewswire/ -- The Biopolymers Market size is expected to grow by USD 14.93 billion, accelerating at a CAGR of 10.11% between 2022 to 2027. The increasing...